Structures by: Gyepesová D.
Total: 14
(1-Methylimidazole)(N-salicylidene-rac-glutamato)copper(II)
C16H17CuN3O5
Acta Crystallographica Section E (2003) 59, 12 m1181-m1183
a=7.92940(10)Å b=11.33050(10)Å c=18.53870(10)Å
α=90.00° β=98.7070(10)° γ=90.00°
1,2:4,5-di-O-isopropylidene-β-D-erythro-hexo-2,3-diulo-2,6 -pyranose
C12H18O6
Acta Crystallographica Section E (2001) 57, 8 o672-o674
a=10.9909(2)Å b=10.5488(2)Å c=11.3876(2)Å
α=90.00° β=100.5260(10)° γ=90.00°
(N-Salicylidene-DL-glutamato)(2-methylimidazole)copper(II)
C16H17CuN3O5
Acta Crystallographica Section E (2004) 60, 1 m129-m132
a=5.23190(10)Å b=16.2576(3)Å c=9.60440(10)Å
α=90.00° β=96.5300(10)° γ=90.00°
C6H6K2N1O7V,2(H2O1)
C6H6K2N1O7V,2(H2O1)
Acta Crystallographica Section C (1993) 49, 5 867-870
a=7.597(5)Å b=12.951(3)Å c=13.131(5)Å
α=90° β=90° γ=90°
BKO6Si2
BKO6Si2
Acta Crystallographica Section C (1992) 48, 10 1831-1832
a=12.618(4)Å b=12.618(4)Å c=12.618(4)Å
α=90° β=90° γ=90°
2-(2-hydroxyphenyl)-2-oxazoline
C9H9NO2
Acta Crystallographica Section C (2005) 61, 10 o602-o606
a=5.75620(10)Å b=11.24640(10)Å c=12.13650(10)Å
α=90.00° β=98.1620(10)° γ=90.00°
2-(3-hydroxyphenyl)-2-oxazoline
C9H9NO2
Acta Crystallographica Section C (2005) 61, 10 o602-o606
a=11.3650(2)Å b=12.58670(10)Å c=11.2966(2)Å
α=90.00° β=99.5340(10)° γ=90.00°
2-(4-hydroxyphenyl)-2-oxazoline
C9H9NO2
Acta Crystallographica Section C (2005) 61, 10 o602-o606
a=4.77780(10)Å b=14.9883(2)Å c=10.91940(10)Å
α=90.00° β=95.9450(10)° γ=90.00°
Bis[μ-hydrogen <i>N</i>-(2-oxidobenzylidene)-DL-glutamato]bis[(isoquinoline)copper(II)] ethanol disolvate
C42H36Cu2N4O10,2(C2H6O)
Acta Crystallographica Section C (2009) 65, 5 m208-m210
a=9.4211(16)Å b=10.949(3)Å c=12.565(3)Å
α=66.477(5)° β=69.288(3)° γ=69.139(3)°
<i>trans</i>-bis(ethanol-κ<i>O</i>)tetrakis(1<i>H</i>-imidazole- κ<i>N</i>^3^)copper(II) bis[μ-<i>N</i>-(2-oxidobenzylidene)-D,L-glutamato]- κ^4^<i>O</i>^1^,<i>N</i>,<i>O</i>^2^:<i>O</i>^2'^;\ κ^4^<i>O</i>^2'^:<i>O</i>^1^,<i>N</i>,<i>O</i>^2'^-bis[(1<i>H</i>-imidazole- κ<i>N</i>^3^)cuprate(II)]
C16H28CuN8O22,C30H28Cu2N6O102
Acta Crystallographica Section C (2012) 68, 11 m326-m328
a=8.02750(10)Å b=9.94010(10)Å c=16.84440(10)Å
α=96.6070(10)° β=95.1340(10)° γ=96.3940(10)°
Anti-2-Hydroxy-2-methyl-1-tetralone oxime
C11H13NO2
Acta Crystallographica Section C (2006) 62, 4 o199-o202
a=7.3655(2)Å b=9.6851(2)Å c=14.47200(10)Å
α=93.3750(10)° β=99.4760(10)° γ=102.2880(10)°
Decacalcium hexakis[chromate(V)] chromate(VI)
7(CrO4),10(Ca)
Acta Crystallographica Section C (2013) 69, 2 111-113
a=10.75800(10)Å b=10.75800(10)Å c=38.0730(3)Å
α=90.00° β=90.00° γ=120.00°
2-(4-hydroxyphenyl)-4,4-dimethyl-2-oxazoline
C11H13NO2
Acta Crystallographica Section C (2006) 62, 7 o416-o418
a=12.1590(2)Å b=8.56660(10)Å c=9.99990(10)Å
α=90.00° β=90.00° γ=90.00°
2-(2,5-dihydroxyphenyl)-2-oxazoline
C9H9NO3
Acta Crystallographica Section C (2007) 63, 3 o187-o189
a=24.4297(3)Å b=31.7167(7)Å c=4.44090(10)Å
α=90.00° β=90.00° γ=90.00°